BRK-B vs DBL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DBL exhibits severe financial distress indicators, headlined by a critical Piotroski F-Score of 1/9, signaling weak fundamental health. The asset is currently trading at a significant premium to its intrinsic value of $7.56, while the 122.22% dividend payout ratio indicates an unsustainable yield that likely erodes capital. With a 0/100 technical trend and zero reported operating margins, the fund appears to be a value trap. The combination of poor health scores and overvaluation suggests a high risk of price correction.
Compare Another Pair
Related Comparisons
BRK-B vs DBL: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and DoubleLine Opportunistic Credit Fund (DBL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.